|
|
Volumn 349, Issue 5, 2003, Pages 419-421
|
|
The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROTEIN;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VON HIPPEL LINDAU PROTEIN;
BEVACIZUMAB;
ENDOTHELIAL CELL GROWTH FACTOR;
LIGASE;
LYMPHOKINE;
MONOCLONAL ANTIBODY;
SIGNAL PEPTIDE;
TUMOR SUPPRESSOR PROTEIN;
UBIQUITIN PROTEIN LIGASE;
VASCULOTROPIN A;
VHL PROTEIN, HUMAN;
ANGIOGENESIS;
CARCINOGENESIS;
GENE INACTIVATION;
HUMAN;
KIDNEY CANCER;
PRIORITY JOURNAL;
REVIEW;
TUMOR SUPPRESSOR GENE;
VON HIPPEL LINDAU DISEASE;
ADENOCARCINOMA;
DISEASE FREE SURVIVAL;
DRUG ANTAGONISM;
GENE SILENCING;
GENETICS;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
NEOVASCULARIZATION (PATHOLOGY);
NOTE;
ADENOCARCINOMA, CLEAR CELL;
ANTIBODIES, MONOCLONAL;
CARCINOMA, RENAL CELL;
DISEASE-FREE SURVIVAL;
ENDOTHELIAL GROWTH FACTORS;
GENE SILENCING;
GENES, TUMOR SUPPRESSOR;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
KIDNEY NEOPLASMS;
LIGASES;
LYMPHOKINES;
NEOVASCULARIZATION, PATHOLOGIC;
TUMOR SUPPRESSOR PROTEINS;
UBIQUITIN-PROTEIN LIGASES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;
|
|
EID: 0042342564
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp030061 Document Type: Review |
|
Times cited : (151)
|
|
References (3)
|
